Telemedicine Approaches to Evaluating Acute-phase ROP
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Graham E Quinn, MD, MSCE
Children's Hospital of Philadelphia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary
Calgary, Alberta, Canada
- University of Louisville
Louisville, Kentucky, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Duke University
Durham, North Carolina, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- University of Oklahoma
Oklahoma City, Oklahoma, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Texas San Antonio
San Antonio, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2011
- Primary completion
- 31 Oct 2013
- Completion
- 31 Jan 2014
- Last update posted
- 4 Feb 2015
- Registered enrollment
- 269
- Registry id
- NCT01264276
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.